Inventor

ERICKSON SHAWN DAVID

US36 patents

⚠️ This page may combine multiple inventors who share the name “ERICKSON SHAWN DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ERICKSON SHAWN DAVID

HOFFMANN LA ROCHE

Substituted isoxazole amide compounds as inhibitors of stearoyl-CoA desaturase 1 (SCD1)

4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds

Substituted isoxazole amine compounds as inhibitors of SCD1

Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists

Inhibitors of stearoyl-CoA desaturase

Diaminocycloalkane MCH receptor antagonists

6-aminoindole derivatives as TRP channel antagonists

Acetamide derivatives

3-amino-pyridines as GPBAR1 agonists

Antiviral compounds

Antiviral compounds

Imidazopyridine derivatives

Substituted carbamate compounds

Substituted phenylcarbamate compounds

1,2-pyridazines, 1,6-pyridazines and pyrimidines

Substituted sulfonamide compounds

MCH receptor antagonists

Antiviral compounds

BERLEX LAB

N-heterocyclic derivatives as NOS inhibitors

N-heterocyclic derivatives as NOS inhibitors

N-heterocyclic derivatives as NOS inhibitors

N-heterocyclic derivatives as NOS inhibitors

N-heterocyclic derivatives as NOS inhibitors

N-heterocyclic derivatives as NOS inhibitors

N-heterocyclic derivatives as NOS inhibitors

N-heterocyclic derivatives as nos inhibitors

BISSANTZ CATERINA

3-amino-pyridines as GPBAR1 agonists

4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds

1-hydroxyimino-3-phenyl-propanes

PHARMACOPEIA DRUG DISCOVERY

Pyrimidine and triazine kinase inhibitors

N-heterocyclic derivatives as NOS inhibitors

Pyrimidine derivatives as IL-8 receptor antagonists

PHARMACEOPEIA INC

N-heterocyclic inhibitors of TNF-α expression

PHARMACOPEIA INC

N-heterocyclic inhibitors of TNF-α expression

ERICKSON SHAWN DAVID

GPR119 receptor agonists

BERLAX LAB INC

N-heterocyclic derivatives as NOS inhibitors